Characterizing primary and secondary senescence in vivo
- PMID: 40646305
- DOI: 10.1038/s43587-025-00917-y
Characterizing primary and secondary senescence in vivo
Abstract
There is robust evidence that senescence can be propagated in vitro through mechanisms including the senescence-associated secretory phenotype, resulting in the non-cell-autonomous induction of secondary senescence. However, the induction, regulation and physiological role of secondary senescence in vivo remain largely unclear. Here we generated senescence-inducible mouse models expressing either the constitutively active form of MEK1 or MKK6 and mCherry, to map primary and secondary senescent cells. Our models recapitulate characteristic features of senescence and demonstrate that primary and secondary phenotypes are highly tissue- and inducer-dependent. Spatially resolved RNA expression analyses at the single-cell level reveal that each senescence induction results in a unique transcriptional profile-even within cells of the same cell type-explaining the heterogeneity of senescent cells in vivo. Furthermore, we show that interleukin-1β, primarily derived from macrophages, induces secondary phenotypes. Our findings provide insight into secondary senescence in vivo and useful tools for understanding and manipulating senescence during aging.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
-
- Munoz-Espin, D. & Serrano, M. Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482–496 (2014). - PubMed
-
- Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436–453 (2018). - PubMed
-
- Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685–705 (2013). - PubMed
-
- Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997). - PubMed
MeSH terms
Substances
Grants and funding
- JP17gm1110004, JP22bm1223002, JP22gm1310002, JP21gm1310011, JP24bm1123053/Japan Agency for Medical Research and Development (AMED)
- JP17gm1110004, JP22bm1223002, JP22ama221201, JP22gm1110004, JP22zf0127008, JP223fa627001/Japan Agency for Medical Research and Development (AMED)
- JPMJCR2023/MEXT | JST | Core Research for Evolutional Science and Technology (CREST)
- JPMJFR206C/MEXT | Japan Science and Technology Agency (JST)
- JPJSA3F20230001/MEXT | Japan Society for the Promotion of Science (JSPS)
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
